The medication(s) listed below have been approved by the Food and Drug Administration (FDA) as orphan products for treatment of this condition.
Learn more orphan products.
Fludarabine phosphate oral tablets
(Brand name: Fludarabine (oral))
- Manufactured by Antisoma
FDA-approved indication: Treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) whose disease has not responded to or has progressed during or after treatment with at least one standard alkylating-agent containing regimen.
National Library of Medicine Drug Information Portal
Medline Plus Health Information